Page last updated: 2024-10-16

adenine and Epstein-Barr Virus Infections

adenine has been researched along with Epstein-Barr Virus Infections in 4 studies

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Yoon, SE1
Kim, SJ1
Yoon, DH1
Koh, Y1
Mun, YC1
Do, YR1
Choi, YS1
Yang, DH1
Kim, MK1
Lee, GW1
Suh, C1
Ko, YH1
Kim, WS1
Law, SC1
Hoang, T1
O'Rourke, K1
Tobin, JWD1
Gunawardana, J1
Loo-Oey, D1
Bednarska, K1
Merida de Long, L1
Sabdia, MB1
Hapgood, G1
Blyth, E1
Clancy, L1
Hennig, S1
Keane, C1
Gandhi, MK1
Vargas, L1
Hamasy, A1
Nore, BF1
Smith, CI1
Hussaini, MO1
Rehman, A1
Chavez, JC1
Pinilla-Ibarz, J1
Horna, P1

Reviews

1 review available for adenine and Epstein-Barr Virus Infections

ArticleYear
Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases.
    Scandinavian journal of immunology, 2013, Volume: 78, Issue:2

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Antineoplastic Agents; Autoimmunit

2013

Trials

1 trial available for adenine and Epstein-Barr Virus Infections

ArticleYear
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the fina
    Annals of hematology, 2020, Volume: 99, Issue:6

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Contro

2020

Other Studies

2 other studies available for adenine and Epstein-Barr Virus Infections

ArticleYear
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021, Volume: 21, Issue:10

    Topics: Adenine; Central Nervous System; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lympho

2021
EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:7

    Topics: Adenine; Antineoplastic Agents; Bone Marrow; Burkitt Lymphoma; Diagnosis, Differential; Disease Prog

2017